RCELAVITA Medical, Inc.
10.06USD-2.71%Mkt Cap: 311.12M $P/E:

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is th…

Key Statistics

Company
Market Cap311.12M $
Enterprise Value349.40M $
Revenue (TTM)75.63M $
Gross Profit58.82M $
Net Income (TTM)-48.59M $
Revenue/Share2.522 USD
Last Price10.06 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees226
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-23.57
PEG
EV/EBITDA-10.66
EV/Revenue4.62
P/S4.13
P/B-11.21
EPS (TTM)-1.40
EPS (Forward)-0.43
52W Range
3.22095% of range10.41
52W High10.41 USD
52W Low3.220 USD
Profitability
Gross Margin82.13%
Oper. Margin-31.59%
EBITDA Margin-43.32%
Profit Margin-67.85%
ROE291.81%
ROA-86.16%
Growth
Revenue Growth17.80%
Earnings Growth
Cash Flow & Leverage
Operating CF-31.20M $
CapEx (TTM)1.74M $
FCF Margin-17.65%
FCF Yield-4.29%
Net Debt37.35M $
Net Debt/EBITDA-1.14
Balance Sheet
Debt/Equity-2.77
Current Ratio0.41
Quick Ratio0.31
Book Value/Sh-0.9000 USD
Cash/Share0.3600 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:5
Split DateJun 30, 2020
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.11 USD
Upside (mean)+10.5%
Target Range8.134 USD14.11 USD
$8.134+10.5% to mean$14.11
# Analysts3
Ownership
Shares Out.30.93M
Float30.47M
Insiders1.51%
Institutions16.02%
Short Interest
Short Ratio9.4d
Short % Float8.51%
Short % Out.8.43%
Shares Short2.61M
Short (prev mo.)2.53M
Technical
SMA 505.261 (+91.2%)
SMA 2004.393 (+129.0%)
Beta1.85
S&P 52W Chg18.16%
Avg Vol (30d)548.85K
Avg Vol (10d)1.32M
Technical Indicators
RSI (14)80.8
MACD1.2652
MACD Signal0.8435
MACD Hist.+0.4217
BB Upper10.46 USD
BB Middle6.311 USD
BB Lower2.162 USD
BB Width131.50%
ATR (14)0.6944 USD
Vol Ratio (20d)0.46x